Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic cases
- 1 April 2002
- journal article
- research article
- Published by Elsevier BV in Thrombosis Research
- Vol. 106 (2), 121-125
- https://doi.org/10.1016/s0049-3848(02)00096-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Hyperhomocyst(e)inemia and the Increased Risk of Venous ThromboembolismArchives of Internal Medicine, 2000
- Meta-analysis of Hyperhomocysteinemia as a Risk Factor for Venous Thromboembolic DiseaseArchives of Internal Medicine, 1998
- Relationship Between Homocysteine and Thrombotic DiseaseThe American Journal of the Medical Sciences, 1998
- Interrelation of Hyperhomocyst(e)inemia, Factor V Leiden, and Risk of Future Venous ThromboembolismCirculation, 1997
- Prevalence of activated protein C resistance and analysis of clinical profile in thromboembolic patients. A Belgian prospective studyJournal of Internal Medicine, 1997
- Hyperhomocysteinemia as a Risk Factor for Deep-Vein ThrombosisNew England Journal of Medicine, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?The Lancet, 1995
- High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994